Lumiares CommV Private Privak and Croes-Bailleul BV take 8.9% and 1.6% stakes in Histofy
Published
Lumiares CommV Private Privak, a fund, entered Histofy Ltd’s register as a holder of ordinary shares in the computational pathology AI firm.
Croes-Bailleul BV also entered the register as a corporate holder of ordinary shares.
The two new non-individual holders coincide with an increase in Histofy’s total share count, suggesting fresh funding. The changes were filed on 25 June 2026 for the period from 10 June 2025 to 10 June 2026.
Shareholder data
Source: Companies House confirmation statement (CS01) — period to , filed .
Changes in this confirmation statement
| Type | Shareholder | Shares | Change | Share classes |
|---|---|---|---|---|
| New shareholder | CROES-BAILLEUL BV | 6,824 | — | ORDINARY 6,824 |
Current shareholders (6)
| Shareholder | Total shares | Share classes |
|---|---|---|
| UNIVERSITY OF WARWICK | 59,324 | ORDINARY 59,324 |
| HISTOFY EMPLOYEE SHARE TRUST | 55,472 | ORDINARY 55,472 |
| SOURCE BIOSCIENCE LIMITED | 21,972 | ORDINARY 21,972 |
| CROES-BAILLEUL BV | 6,824 | ORDINARY 6,824 |
| CAPSTONE HEADWATERS LIMITED | 3,333 | ORDINARY 3,333 |
| ST MICHAEL'S PATHOLOGY SERVICES LTD | 1,220 | ORDINARY 1,220 |
Contact the editorial team at editorial@fundingspotter.com